Adagene (ADAG) grants director 20,000 stock options at $3
Rhea-AI Filing Summary
Adagene Inc. director Cheung Andy Yiu Leung received a grant of 20,000 nonqualified stock options on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan. The options have a $3.00 per-share exercise price, expire on August 13, 2036, and will vest on April 30, 2027 or the date of the next annual 20-F filing, whichever is earlier. Following this award, Cheung holds 90,000 options in total. The Rule 10b5-1 checkbox was not marked as being under a trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Cheung Andy Yiu Leung
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Nonqualified Stock Option (Right to Buy) F1 | 20,000 | $0.00 | $0.00 |
Holdings After Transaction:
Nonqualified Stock Option (Right to Buy) — 90,000 shares (Direct)
Footnotes (1)
- F1. 20,000 shares of stock option granted on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan, and the option shall vest on April 30, 2027 or the date of the next 20-F filing, whichever is earlier.
Key Figures
Options granted: 20,000 shares
Exercise price: $3.0000 per share
Options after transaction: 90,000 shares
+2 more
5 metrics
Options granted
20,000 shares
Nonqualified stock options granted on August 13, 2026
Exercise price
$3.0000 per share
Conversion or exercise price of the granted options
Options after transaction
90,000 shares
Total options held following the reported grant
Expiration date
2036-08-13
Expiration date of the granted options
Vesting date
April 30, 2027
Options vest on this date or the date of the next 20-F filing, whichever is earlier
Key Terms
Nonqualified Stock Option, Performance Incentive Plan, Form 20-F, Rule 10b5-1
4 terms
Nonqualified Stock Option financial
"security_title: Nonqualified Stock Option (Right to Buy)"
A nonqualified stock option (NQSO) is a company grant that gives an individual the right to buy shares at a set price but does not meet special tax rules for incentive stock options; when exercised the difference between the market price and the exercise price is treated as ordinary income for the recipient and as a tax-deductible expense for the company. It matters to investors because NQSOs affect an employee’s after-tax proceeds, the company’s reported expenses, and potential share dilution—think of it like a cash bonus that converts into stock but is taxed as regular pay when you take it.
Performance Incentive Plan financial
"granted on August 13, 2026 under the Adagene Inc. 2021 Performance Incentive Plan"
Form 20-F regulatory
"or the date of the next 20-F filing, whichever is earlier"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
Rule 10b5-1 regulatory
"The Rule 10b5-1 checkbox was not marked as being under a trading plan"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
What equity award did ADAG director Cheung Andy Yiu Leung receive?
Cheung Andy Yiu Leung received a grant of 20,000 nonqualified stock options in Adagene Inc. The award was made on August 13, 2026 under the company’s 2021 Performance Incentive Plan.
What is the exercise price of the new stock options reported for ADAG?
The newly granted options have a $3.00 per-share exercise price. These options allow the holder to buy Adagene ordinary shares at this price once vested and exercised, regardless of future market prices.
When do the newly granted ADAG stock options vest?
The 20,000 options will vest on April 30, 2027 or on the date of Adagene’s next annual Form 20-F filing, whichever occurs earlier, according to the grant footnote.
How many Adagene options does Cheung hold after this Form 4 transaction?
After this grant, Cheung holds 90,000 stock options in total. The Form 4 reports 20,000 options acquired in this award, bringing his reported direct option holdings to that level.
Are the ADAG option transactions reported under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not marked, indicating this specific option grant was not affirmed as made under a Rule 10b5-1 trading plan. It is reported as a standard compensation award.
AI-generated analysis. How Rhea-AI works. Not financial advice.
